Search | WHO COVID-19 Research Database

Impact of COVID-19 Pandemic on TAVR Activity: A Worldwide Registry

Armario, X.; Carron, J.; Abdel-Wahab, M.; Tchetche, D.; Bleiziffer, S.; Lefevre, T.; Modine, T.; Wolf, A.; Pilgrim, T.; Villablanca, P.; Cunnington, M.; Van Mieghem, N.; Hengstenberg, C.; Sondergaard, L.; Swaans, M.; Prendergast, B.; Barbanti, M.; Webb, J.; Uren, N.; Resar, J.; Chen, M.; Hildick-Smith, D.; Spence, M.; Zweiker, D.; Bagur, R.; de Cruz, H.; Ribichini, F.; Park, D. W.; Codner, P.; Wykrzykowska, J.; Bunc, M.; Estevez-Loureiro, R.; Poon, K.; Gotberg, M.; Ince, H.; Latib, A.; Packer, E.; Angelillis, M.; Kobari, Y.; Nombela-Franco, L.; Guo, Y. Q.; Savontaus, M.; Arafat, A. A.; Kliger, C.; Roy, D.; Merkely, B.; Silva, M.; White, J.; Yamamoto, M.; Ferreira, P. C.; Toggweiler, S.; Ohno, Y.; Rodrigues, I.; Ojeda, S.; Voudris, V.; Grygier, M.; Almerri, K.; Cruz-Gonzalez, I.; Fridrich, V.; Hernandez, Jdlt, Piazza, N.; Noble, S.; Arzamendi, D.; Kurt, I. H.; Bosmans, J.; Erglis, M.; Casserly, I.; Sawaya, F.; Bhindi, R.; Kefer, J.; Yin, W. H.; Rosseel, L.; Kim, H. S.; O'Connor, S.; Hellig, F.; Sztejfman, M.; Mendiz, O.; Xuereb, R.; Brito, F.; Bajoras, V.; Balghith, M.; Lee, M. K. Y.; Eid-Lidt, G.; Vandeloo, B.; Vaz, V.; Alasnag, M.; Ussia, G. P.; Mayol, J.; Sardella, G.; Buddhari, W.; Kao, H. L.; Dager, A.; Tzikas, A.; Edris, A.; Gutierrez, L.; Arias, E.; Erturk, M.; Vela, C. N. C.; Boljevic, D.; Guadagnoli, A. F.; ElGuindy, A.; Santos, L.; Perez, L.; Maluenda, G.; Akyuz, A. R.; Alhaddad, I.; Amin, H.; Yu, S. C.; Alnooryani, A.; Albistur, J.; Nguyen, Q.; Mylotte, D..

Journal of the American College of Cardiology ; 80(12):B225-B226, 2022.

Article in English | Web of Science | ID: covidwho-2167597

External validation demonstrates limited clinical utility of the interpretable mortality prediction model for patients with COVID-19 reply

Goncalves, J.; Yan, L.; Zhang, H. T.; Xiao, Y.; Wang, M. L.; Guo, Y. Q.; Sun, C.; Tang, X. C.; Cao, Z. G.; Li, S. S.; Xu, H.; Cheng, C.; Jin, J. Y.; Yuan, Y..

Nature Machine Intelligence ; 3(1):28-32, 2021.

Article in English | Web of Science | ID: covidwho-1127179

Limited applicability of a COVID-19 specific mortality prediction rule to the intensive care setting Reply

Goncalves, J.; Yan, L.; Zhang, H. T.; Xiao, Y.; Wang, M. L.; Guo, Y. Q.; Sun, C.; Tang, X. C.; Cao, Z. G.; Li, S. S.; Xu, H.; Cheng, C.; Jin, J. Y.; Yuan, Y..

Nature Machine Intelligence ; 2020.

Article in English | Web of Science | ID: covidwho-966807

Feasibility analysis of coronavirus disease 2019 co-treated by Zedoary Turmeric Oil Injection

Jiang, C. X.; Guo, Y. Q.; Zhang, S. J.; Cui, Y.; Li, X. X.; Ren, X. Y.; Li, X. K.; Bao, K. D..

Chinese Traditional and Herbal Drugs ; 51(11):3062-3069, 2020.

Article in Chinese | EMBASE | ID: covidwho-682396

ABSTRACT

Because of no specific drug for the treatment of coronavirus disease 2019 (COVID-19), a number of treatment plans for COVID-19 had been released by national medical treatment authorities. The efficacy of zedoary turmeric oil and its preparation for antiviral and pulmonary fibrosis treatment had been confirmed by many basic studies and clinical applications. It was speculated that Zedoary Turmeric Oil Injection could be used in the clinical diagnose and treatment of COVID-19, especially in the treatment of pulmonary fibrosis caused by pulmonary interstitial changes, antidiarrheal and fever. In addition, the compatibility of Zedoary Turmeric Oil Injection with other antiviral and antibiotic drugs suggested that it could be used to reduce drug-induced liver injury in the treatment of COVID-19 patients, and improve the therapeutic effect, which provided a theoretical basis for the scientific use of zedoary turmeric oil and its injection in the treatment of COVID-19.

ABSTRACT

SEND TO:

SELECTION OF CITATIONS

SEARCH DETAIL